Las Cruces, NM, United States of America

Charles B Shuster

This inventor holds 3 USPTO granted patents. Top assignee: Arrowhead Center, Inc.. Active years: 2013-2014.


% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Charles B Shuster

Introduction

Charles B Shuster is a notable inventor based in Las Cruces, NM (US). He has made significant contributions to the field of science and technology, holding a total of three patents. His work primarily focuses on the development of innovative compounds and methods that have potential applications in various industries.

Latest Patents

One of his latest patents is titled "Selective inhibitors of EG5 motors and methods of use." This invention comprises a compound of formula I or its enantiomer, diastereomer, stereoisomer, or its pharmaceutically acceptable salt, along with methods of use and synthesis. Another significant patent is "Synthesis and applications of triazaborolopyridinium compounds and substituted triazaborolopyridinium compounds and methods of use." This invention introduces a class of fluorescent compounds derived from hydrazine-2-yl-pyridine containing a triazaborolopyridinium core, prepared through a stepwise procedure.

Career Highlights

Charles B Shuster is associated with Arrowhead Center, Inc., where he continues to innovate and contribute to research and development. His work has garnered attention for its potential impact on various scientific fields.

Collaborations

He has collaborated with notable colleagues, including Jeffrey Arterburn and Kevin D Houston, enhancing the scope and depth of his research endeavors.

Conclusion

Charles B Shuster's innovative work and patents reflect his commitment to advancing technology and science. His contributions are valuable assets to the field and demonstrate the importance of research and collaboration in driving innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…